Trial Profile
PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX), CISPLATINUM AND FLUOROURACIL AS CONTINUOUS INFUSION (CCF) IN LOCALLY ADVANCED BREAST CANCER.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2011
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Doxorubicin liposomal (Primary) ; Fluorouracil (Primary) ; Letrozole; Triptorelin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 16 Jun 2011 New trial record